Catalyst Crew Technologies Corp. (OTC: CCTC), a digital health and artificial intelligence technology company, announced today that it is advancing early-stage deployment, testing, and regulatory alignment for its telehealth platform in Venezuela. The company is actively evaluating system performance, user workflows, and operational capabilities through its digital interface at https://latamedai.org as part of its initial launch activities.
The platform is designed to support remote patient engagement, care coordination, and the integration of AI-driven healthcare analytics tools. Current efforts focus on enhancing functionality, improving data integration, and optimizing the user experience. In parallel, the company is working with the Ministerio del Poder Popular para la Salud, including the Servicio Autónomo de Contraloría Sanitaria (SACS), to obtain the required Permiso Sanitario de Funcionamiento para Plataforma Digital. Management anticipates the permitting process may be completed in the near term, but no assurance can be provided regarding timing or outcome.
Dr. Kevin Rodan Levy, CEO of Catalyst Crew Technologies, stated: “Our focus is on building a scalable telehealth platform that can operate effectively within real-world healthcare environments. We are currently advancing platform testing, refinement, and regulatory alignment as we continue to build the foundation for broader deployment across Latin America. We expect a full launch in short order and upon receiving all regulatory approvals.”
This phase of deployment, testing, and regulatory alignment represents an important step toward broader operational rollout across target markets. The company continues to develop its digital health and AI platform, including telehealth infrastructure and AI-driven analytics capabilities. For more information, visit https://catalystcrewai.com or review the company’s filings with the U.S. Securities and Exchange Commission at www.sec.gov.
The implications of this announcement are significant for emerging markets, particularly in Latin America, where access to modernized healthcare delivery systems is in high demand. If successful, Catalyst Crew’s platform could improve care coordination, remote patient monitoring, and data analytics in regions with limited healthcare infrastructure. However, as a development-stage enterprise, the company has not yet generated revenues from its new business direction, and there are risks associated with securing regulatory approvals, financing, and market adoption.
The company’s forward-looking statements highlight these uncertainties, noting that actual results may differ materially due to factors such as the ability to implement its business plan, comply with regulatory requirements, and general economic conditions. Investors are urged to review risk factors in the company’s SEC filings before making investment decisions.
